The prognostic role of SOX11 is not well‐established, with different studies showing different conclusions.11, 12 TP53 mutation has been identified a prognostic factor that predicts poor outcome in MCL patients.13, 14 However, the mutation status of TP53 is not routinely examined in most pathology laboratories. The gene discussed is SOX11; the disease is mantle cell lymphoma.